AAAAAA

   
Results: 1-3 |
Results: 3
USE OF XENOGENEIC CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) IN A PLASMID-BASED VACCINE TO PRODUCE ANTI-CETP AUTOANTIBODIES FOR THE PREVENTION TREATMENT OF ATHEROSCLEROSIS/
Authors: THOMAS LJ ADARI H PICARD MD HONAN CM MILLER DP RITTERSHAUS CW PETTEY CL
Citation: Lj. Thomas et al., USE OF XENOGENEIC CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) IN A PLASMID-BASED VACCINE TO PRODUCE ANTI-CETP AUTOANTIBODIES FOR THE PREVENTION TREATMENT OF ATHEROSCLEROSIS/, The FASEB journal, 12(4), 1998, pp. 1805-1805
A PLASMID-BASED VACCINE TO ELICIT AUTOANTIBODIES TO CHOLESTERYL ESTERTRANSFER PROTEIN (CETP) FOR THE PREVENTION TREATMENT OF ATHEROSCLEROSIS/
Authors: THOMAS LJ PICARD MD STEWART SE WAITE BCD LIN AY RITTERSHAUS CW PETTEY CL
Citation: Lj. Thomas et al., A PLASMID-BASED VACCINE TO ELICIT AUTOANTIBODIES TO CHOLESTERYL ESTERTRANSFER PROTEIN (CETP) FOR THE PREVENTION TREATMENT OF ATHEROSCLEROSIS/, Journal of allergy and clinical immunology, 99(1), 1997, pp. 754-754
CHARACTERIZATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR THE V-BETA-3 FAMILY OF THE HUMAN T-CELL RECEPTOR GENERATED USING SOLUBLE TCR BETA-CHAIN
Authors: CALAMAN SD CARSON GR HENRY LD KUBINEC JS KUESTNER RE AHMED A WILSON EM LIN AY RITTERSHAUS CW MARSH HC JONES NH
Citation: Sd. Calaman et al., CHARACTERIZATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR THE V-BETA-3 FAMILY OF THE HUMAN T-CELL RECEPTOR GENERATED USING SOLUBLE TCR BETA-CHAIN, Journal of immunological methods, 164(2), 1993, pp. 233-244
Risultati: 1-3 |